Search company, investor...

VentriFlo

ventriflo.com

Founded Year

2019

Stage

Series A | Alive

Total Raised

$10M

Last Raised

$10M | 3 yrs ago

About VentriFlo

The VentriFlo True Pulse Pump is a pulsatile blood pumping system designed to achieve superior outcomes, reduce costs and improve safety for pediatric and adult patients who require cardiopulmonary support during surgery or in the ICU.

Headquarters Location

70 Bridge St

Pelham, New Hampshire, 03076,

United States

(603) 459-0710

Missing: VentriFlo's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: VentriFlo's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing VentriFlo

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

VentriFlo is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

8,606 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health IT

7,901 items

VentriFlo Patents

VentriFlo has filed 6 patents.

The 3 most popular patent topics include:

  • Linear motor metros
  • Pumps
  • Fluid dynamics
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/23/2021

1/10/2023

Pumps, Fluid dynamics, Marine diesel engines, Diesel locomotive engines, Congenital heart defects

Grant

Application Date

2/23/2021

Grant Date

1/10/2023

Title

Related Topics

Pumps, Fluid dynamics, Marine diesel engines, Diesel locomotive engines, Congenital heart defects

Status

Grant

Latest VentriFlo News

VentriFlo Closes $10M Series A Funding

Sep 20, 2019

VentriFlo, Inc. , a Pelham, N.H.-based developer of a a blood pumping platform, closed a $10m Series A funding. The round was led by Jim and Pat Poitras and other investors. The company intends to use the funds to continue the development and FDA 510(k) submission for its patented platform. Led by Doug Vincent, President & CEO, VentriFlo is advancing tre VentriFlo® True Pulse Pump™, which is capable of replicating the native heartbeat by delivering blood flow with a life-like pulse during surgery or in the ICU. VentriFlo True Pulse Pumps are under development, for investigational use only, and are not available for commercial sale. The company was originated from Design Mentor, Inc., a NH corporation with a history of medical device design and development, specializing in fluid pumping. FinSMEs

VentriFlo Frequently Asked Questions (FAQ)

  • When was VentriFlo founded?

    VentriFlo was founded in 2019.

  • Where is VentriFlo's headquarters?

    VentriFlo's headquarters is located at 70 Bridge St, Pelham.

  • What is VentriFlo's latest funding round?

    VentriFlo's latest funding round is Series A.

  • How much did VentriFlo raise?

    VentriFlo raised a total of $10M.

  • Who are the investors of VentriFlo?

    Investors of VentriFlo include Jim Poitras and Pat Poitras.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.